UK Government signs deal with drugs giant GSK for 60 million doses of potential coronavirus vaccine
University of Oxford Oxford University academics began developing the ChAdOx1 nCoV-19 vaccine in January. It is now named AZD1222, after the researchers signed a manufacturing partnership with pharmaceutical giant AstraZeneca. Human trials started on April 23 and they are now in the final phase, with trials being carried out in the UK, Brazil and South … Read more